Oncotarget How Low Oxygen Shields Prostate Cancer from Ferroptosis Therapies Preclinical and clinical studies indicate that ferroptosis suppresses tumor growth, and dysregulation of ferroptosis promotes... read more November 6, 2025
Oncotarget Genetic Study Identifies Potential Diagnostic Marker for Rare Blood Cancer BPDCN Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with poorly characterized molecular... read more October 22, 2025
Oncotarget New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil In non–small cell lung cancer (NSCLC), alterations in the HER2 (ERBB2) gene define a... read more October 8, 2025
Oncotarget Amivantamab Monotherapy in Rare EGFR-Mutated Advanced NSCLC Amivantamab, an anti-EGFR/MET bispecific antibody, shows efficacy in EGFR-mutated NSCLC, but its role in... read more August 26, 2025
Oncotarget Cigarette Smoke and Weak DNA Repair: A Double Hit Behind Lung Cancer Risk Lung cancer remains the leading cause of cancer-related fatalities in the United States and worldwide,... read more August 11, 2025
Oncotarget A New Way to Target Resistant Prostate Cancer Cells Currently, there is no effective therapy for CRPC."Prostate cancer is the second most diagnosed... read more July 29, 2025
Oncotarget PRDX1 Identified as Key to Chemotherapy Resistance in Cancer Cells targeting PRDX1 should sensitize tumours to DNA-damaging agents."Scientists have uncovered a promising new strategy... read more July 14, 2025
Oncotarget Immunotherapy Safety for Hepatocellular Carcinoma in Latin America: Insights from a Real-World Study Latin America has been underrepresented in trials evaluating immunotherapy for hepatocellular carcinoma (HCC)."Liver cancer,... read more July 2, 2025
Oncotarget Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model There are more than 13,000 new cases of malignant brain tumors diagnosed each year... read more June 4, 2025
Oncotarget Engineered Proteins Show Promise in Stopping Glioblastoma Invasion The results demonstrated that the minimal TIMP variants, mTC1, and mTC3, effectively inhibit MMP activity... read more May 21, 2025